These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 35456894)

  • 41. Misfolded SOD1 inclusions in patients with mutations in
    Forsberg K; Graffmo K; Pakkenberg B; Weber M; Nielsen M; Marklund S; Brännström T; Andersen PM
    J Neurol Neurosurg Psychiatry; 2019 Aug; 90(8):861-869. PubMed ID: 30992335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of Cellular Pathway Disturbances on Misfolded Superoxide Dismutase-1 in Fibroblasts Derived from ALS Patients.
    Keskin I; Forsgren E; Lange DJ; Weber M; Birve A; Synofzik M; Gilthorpe JD; Andersen PM; Marklund SL
    PLoS One; 2016; 11(2):e0150133. PubMed ID: 26919046
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A copper-deficient form of mutant Cu/Zn-superoxide dismutase as an early pathological species in amyotrophic lateral sclerosis.
    Tokuda E; Nomura T; Ohara S; Watanabe S; Yamanaka K; Morisaki Y; Misawa H; Furukawa Y
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2119-2130. PubMed ID: 29551730
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations.
    Finelli MJ; Liu KX; Wu Y; Oliver PL; Davies KE
    Hum Mol Genet; 2015 Jun; 24(12):3529-44. PubMed ID: 25792726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
    Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
    Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protein disulphide isomerase (PDI) is protective against amyotrophic lateral sclerosis (ALS)-related mutant Fused in Sarcoma (FUS) in in vitro models.
    Parakh S; Perri ER; Vidal M; Sultana J; Shadfar S; Mehta P; Konopka A; Thomas CJ; Spencer DM; Atkin JD
    Sci Rep; 2021 Sep; 11(1):17557. PubMed ID: 34475430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional diversity between HSP70 paralogs caused by variable interactions with specific co-chaperones.
    Serlidaki D; van Waarde MAWH; Rohland L; Wentink AS; Dekker SL; Kamphuis MJ; Boertien JM; Brunsting JF; Nillegoda NB; Bukau B; Mayer MP; Kampinga HH; Bergink S
    J Biol Chem; 2020 May; 295(21):7301-7316. PubMed ID: 32284329
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genotype-property patient-phenotype relations suggest that proteome exhaustion can cause amyotrophic lateral sclerosis.
    Kepp KP
    PLoS One; 2015; 10(3):e0118649. PubMed ID: 25798606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L
    J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
    Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
    Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis.
    Deng HX; Zhai H; Bigio EH; Yan J; Fecto F; Ajroud K; Mishra M; Ajroud-Driss S; Heller S; Sufit R; Siddique N; Mugnaini E; Siddique T
    Ann Neurol; 2010 Jun; 67(6):739-48. PubMed ID: 20517935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prion Properties of SOD1 in Amyotrophic Lateral Sclerosis and Potential Therapy.
    Sibilla C; Bertolotti A
    Cold Spring Harb Perspect Biol; 2017 Oct; 9(10):. PubMed ID: 28096265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
    Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S
    Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein misfolding in the late-onset neurodegenerative diseases: common themes and the unique case of amyotrophic lateral sclerosis.
    Mulligan VK; Chakrabartty A
    Proteins; 2013 Aug; 81(8):1285-303. PubMed ID: 23508986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS.
    Leyton-Jaimes MF; Benaim C; Abu-Hamad S; Kahn J; Guetta A; Bucala R; Israelson A
    Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10198-203. PubMed ID: 27551074
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis.
    Kaur SJ; McKeown SR; Rashid S
    Gene; 2016 Feb; 577(2):109-18. PubMed ID: 26657039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. From molecule to molecule and cell to cell: prion-like mechanisms in amyotrophic lateral sclerosis.
    Grad LI; Fernando SM; Cashman NR
    Neurobiol Dis; 2015 May; 77():257-65. PubMed ID: 25701498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis.
    Walker AK; Farg MA; Bye CR; McLean CA; Horne MK; Atkin JD
    Brain; 2010 Jan; 133(Pt 1):105-16. PubMed ID: 19903735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DnaJC7 binds natively folded structural elements in tau to inhibit amyloid formation.
    Hou Z; Wydorski PM; Perez VA; Mendoza-Oliva A; Ryder BD; Mirbaha H; Kashmer O; Joachimiak LA
    Nat Commun; 2021 Sep; 12(1):5338. PubMed ID: 34504072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: implication for protein aggregation and immune response.
    Bendotti C; Marino M; Cheroni C; Fontana E; Crippa V; Poletti A; De Biasi S
    Prog Neurobiol; 2012 May; 97(2):101-26. PubMed ID: 22033150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.